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Abstract
AIM: To observe the effect of b-ionone on the proliferation
of human gastric adenocarcinoma cell line SGC-7901 and
the inhibition of metalloproteinase.
METHODS: Using growth inhibition, Zymograms assays
and reverse transcription-polymerase-chain reaction (RT-
PCR), we examined cell growth rates, activities of matrix
metalloproteinases-2 (MMP-2) and -9 (MMP-9), and expression
of metalloproteinases-1 (TIMP-1) and -2 (TIMP-2) in SGC-
7901 cells after the treatment with b-ionone for 24 h and
48 h, respectively.
RESULTS: b-ionone had an inhibitory effect on the growth
of SGC-7901 cells. Eight days after the treatment with b-
ionone at concentrations of 25, 50, 100 and 200 mmol/L,
the inhibition rates were 25.9%, 28.2%, 74.4% and 90.1%,
respectively. The IC50 value of b-ionone for SGC-7901 cells
was estimated to be 89 mmol/L. The effects of b-ionone on
MMP-2 and MMP-9 activities in SGC-7901 cells were not
observed. However, the levels of TIMP-1 and TIMP-2
transcripts were elevated in cells treated with b-ionone in a
dose-dependent manner.
CONCLUSION: b-ionone can inhibit the proliferation of SGC-
7901 cells, upregulate the expression of TIMP-1 and TIMP-
2 expression, and may influence metastasis of cancer.
Liu JR, Yang BF, Chen BQ, Yang YM, Dong HW, Song YQ. Inhibition
of b-ionone on SGC-7901 cell proliferation and upregulation of
metalloproteinases-1 and -2 expression. World J Gastroenterol
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INTRODUCTION
Epidemiological data showed that regular consumption of fruits
and vegetables was associated with a reduced risk of chronic
diseases such as cancer and cardiovascular diseases[1-4]. Isoprenoid
is an important group of nutritious elements found in fruits,
vegetables and cereal grains, giving rise to about 22 000
secondary products during its metabolism in these plants. It
has been found that these compounds shared a common
precursor, mevalonic acid[14]. Isoprenoids have been shown to
suppress chemically-induced carcinogenesis[5-10] and the growth
of cancer cells[11-13]. b-ionone, an end-ring analog of b-carotenoid,
represents a subclass of cyclic isoprenoids and has been
demonstrated to have an anticancer effect[15]. b-ionone was
effective in chemoprevention of 7,12-dimethylben[a]
anthracene-induced mammary carcinogenesis in SD rats, with
its tumor multiplicity reduced by 45%[16]. It has also been found
to be associated with growth inhibition of melanoma and breast
cancer cells as well as metastasis of tumor cells[17-20]. However,
the exact mechanisms remain to be clarified, and the effect of
b-ionone on gastric cancer cells is unknown.
      Chemoprevention has been an approach to treat advanced
cancers[21-25]. Gastric cancer is one of the most common
malignancies in China and in other parts of the world[26-34].
Understanding the mechanisms of the possible inhibitory effect
of b-ionone on proliferation of gastric adenocarcinoma cells
could provide a way to prevent this disease. Therefore, in this
study, we studied the effect of b-ionone on the proliferation of
human gastric adenocarcinoma cell line SGC-7901 and on the
regulative factors of tissue metalloproteinases and investigated
the underlying mechanism.
MATERIALS AND METHODS
Cell culture
Human gastric adenocarcinoma cell line SGC-7901, provided
by Beijing Cancer Research Institute, was grown in RPMI 1640
medium (Gibco BRL, Life Technologies Inc, Gaithersburg, MD,
USA), supplemented with 100 ml/L calf serum, 100×103 U/L
penicillin and 100 mg/L streptomycin at 37  in a humidified
atmosphere containing 5% CO2.
IC50 and cell growth assessment
b-ionone (purity>95%) (Sigma, USA) was dissolved in absolute
ethanol and further diluted to the concentrations of 25, 50,
100 and 200 mmol/L, respectively.
     The SGC-7901 cells were seeded into six 24-well plates
(Nuc, Denmark) with 2×104 cells/well after 24 h culture.
Twenty-four hour later, the medium was replaced with the
media supplemented with at different concentrations of b-
ionone. In the next 8 days, the cells were treated with a trysin-
EDTA solution at 37  for 2 minutes and harvested from 3
wells per day for each plate. The cells were pelleted by a short
spin at 1 000 g and resuspended in phosphate-buffered saline
(PBS). Typan blue exclusion test was used to count viable cells
by a hemocytometer. The number of cells at 24 h was deducted
from the final cell counts to provide an estimate of the net
increase. The b-ionone concentration required to inhibit the
net increase in the 48 h cell count by 50% (IC50) was measured
by plotting data obtained from three or more times. The means
were obtained on each of the eight days and used to draw a
cell growth curve. The inhibitory rate (IR) was calculated
according to the formula: IR (%) = (total number of cells in
168                  ISSN 1007-9327      CN 14-1219/ R        World J Gastroenterol    January 15, 2004   Volume 10   Number 2
negative control - number of cells in test group)/total number
of cells in negative control ×100%.
Zymograms assay for activities of gelatinase
Although many kinds of proteinase are involved in tumor
metastasis, members of the matrix metalloproteinase (MMPs,
gelatinase) and TIMP families, play a pivotal role in these
events. MMPs are a group of zinc-dependent endopeptidase
molecules that have the potential to degrade proteins of the
extracellular matrix. MMP activity was under regulation at
several levels, including activation of the MMP zymogens and
specific inhibition by the tissue inhibitors of metalloproteinase
(TIMPs)[54]. We determined the activities of gelatinase in SGC-
7901 cells treated with b-ionone.
     The SGC-7901 cells were seeded in 100 ml bottles, each
containing 5×106 cells. After incubation for 24 h, the medium
was replaced with 400 mL of serum-free medium supplemented
with b-ionone at different concentrations for 24 h and 48 h.
The serum-free media were loaded onto a 100 g/L SDS-
polyacrylamide gel co-polymerized with 1 g/L gelatin
(Amresco Corp, USA) and separated under a non-denaturing
condition for 3-4 h. Then, the gels were incubated in 25 g/L
Triton X-100 (Sigma, USA) for 1 h and subsequently in a
substrate buffer (50 mmol/L Tris, pH 7.5, containing 10 mmol/L
CaCl2, 200 mmol/L NaCl and 1 mmol/L ZnCl2) for 12 to 16 h
at 37 . Finally, the gels were stained in a solution containing
1 g/L Commassie blue R250, 450 g/L methanol and 100 g/L
acetic acid, and the gelatinolytic activity was indicated by bands
in a blue background.
RT-PCR
Tissue inhibitor of TIMP-1 and TIMP-2 were related to several
tumorigenic processes in lung, stomach, and mammary gland[56].
We examined the expression of TIMP-1 and TIMP-2 in SGC-
7901 cells exposed to different concentrations of b-ionone.
    SGC-7901 cells (5×106) were incubated at different
concentrations of b-ionone for 24 h and 48 h, the total cellular
RNA was isolated. Concentrations and purity of total RNA
were determined. RT-PCR was performed following the
manufacturer’s instructions (Takara Biotech, Dalian, China).
Total RNA (5 µg) and AMV reverse transcriptase XL were
used to synthesize cDNA. Twenty-five mL PCR mixture
containing 4 mL of RT reaction product, 2.5 U Taq DNA
polymerase and 20 pmol primers, was heated for 5 min at
94  for pre-denaturation, and then subjected to 35 PCR
cycles, denaturation at 94  for  30 s, annealing at 60   for
30 s for and extension at 72  for 45 s, in a PTC-100
thermocycler (MJ Research, USA). TIMP-1 and TIMP-2 genes
were amplified with specific primers, with the gene for b-actin
as an internal control (Table 1). The amplified products were
resolved in a 20 g/L agarose gel containing ethidium bromide,
and visualized under ultraviolet light. The density and area of
each band were analyzed using the ChemiImagerTM 4 000
digital system (Alpha Innotech Corp, USA).
Table 1  Primer sequences and size of TIMP-1 and TIMP-2 in
expected PCR products for RT-PCR
Genes   Primer sequences                         Product
         size (bp)
TIMP-1   Sense: 5’-CTGTTGGCTGTGAGGAATGCACAG-3’ 106
  Antisense: 5’-TTCAGAGCCTTGGAGGAGCTGGTC-3’
TIMP-2   Sense: 5’-AGACGTAGTGATCGGGCCA-3’ 490
  Antisense: 5’-GTACCACGCGCAAGAACCT-3’
b-actin   Sense: 5’-AAGGATTCCTATGTGGGC-3’ 532
  Antisense: 5’-CATCTCTTGCTCGAAGTC-3’
Statistical analysis
Student’t test was used for analysis of data. P<0.05 was
considered statistically significant.
RESULTS
Cell growth inhibition of b-ionone
The inhibitory effect of b-ionone on the growth of SGC-7901
cells was shown in Figure 1. Growth of the cells in the media
containing 200 mmol/L and 100 mmol/L b-ionone was markedly
slower than that of the negative control within 8 d (P<0.01).
The change was less obvious the cells treated with 50 mmol/L
and 25 mmol/L of b-ionone. The inhibitory rates were 25.9%,
28.2%, 74.4% and 90.1%, respectively. The IC50 of b-ionone
was 89 mmol/L.
Figure 1  Proliferation kinetics of SGC-7901 cells treated at vari-
ous concentrations of b-ionone.
Expression of type IV collagenases
The effects of b-ionone on type IV collagenase activities (97kD
for MMP-9 and 72kD for MMP-2) in SGC-7901 cells were
presented in Figure 2. In the serum-free supernatants of SGC-
7901 cells preincubated in the media supplemented with
various concentrations of b-ionone, the activities of type IV
collagenases (both MMP-9 and MMP-2) were not different in
comparison with the negative control. No effect of b-ionone
on the activities of type IV collagenases in SGC-7901 cells
was shown.
Figure 2  Effect of b-ionone on  gelatinase/type IV collagenase
secretion (97kD for MMP-9 and 72kD for MMP-2) in SGC-7901
cells.
Levels of TIMP-1 and TIMP-2 mRNA in SGC-7901 cells
As shown in Figures 3 and 4, the levels of TIMP-1 and TIMP-
2 transcripts in SGC-7901 cells were gradually elevated with
increase of the b-ionone concentration, indicating a upregulation
effect of b-ionone on the expression of TIMP-1 and TIMP-2
in SGC-7901 cells.
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Figure 3  RT-PCR result: expression of TIMP-1 mRNA in SGC-
7901 cells treated by b-ionone for 24 h (A) and 48 h (B). C: area
of peaks; Lanes 1-5: 0, 25, 50, 100 and 200 mmol/L of b-ionone;
M: molecular weight markers.
Figure 4  RT-PCR results showing expression of TIMP-2 mRNA
in SGC-7901 cells treated by b-ionone for 24 h (A) and 48 h (B).
C: chart of area of peaks; Lanes 1-5: 0, 25, 50, 100 and 200 mmol/L
of b-ionone; M: molecular weight markers.
DISCUSSION
Interactions between cells and extracellular matrix (ECM) were
critical for many cellular functions including division,
migration, differentiation, and apoptosis[35]. In different mature
normal tissues, ECM is specified by its structures and
compositions to maintain tissue homeostasis and cellular
quiescence. It have been found that remodeling of the ECM
occurred during embryonic development and certain normal
pathological processes such as wound-healing[36,37]. However,
restructuring of the ECM has also been implicated in the
pathogenesis of various human diseases including impaired
wound-healing and fibrosis[38], rheumatoid arthritis[39],
restenosis following balloon angioplasty[40], atherosclerosis[41],
tumor development, invasion and metastasis[35,42].
     Tumor invasion is a complex biological process, during
which tumor cells detach from the primary tumor and infiltrate
the surrounding tissues. This process has been found to require
loss of cell contacts between tumor cells, active cell migration,
adhesion to ECM and proteolytic degradation of the ECM[43,44].
Different molecules including cadherins, integrins, proteases,
and growth factors were implicated in the regulation of invasion
of tumor cells[44].
      A major group of enzymes responsible for ECM degradation
in cancer tissue has been found to be the MMP family, including
collagenases, gelatinase, and stromelysins[45-49]. Collagenases
can cleave fibrillar collagens at neutral conditions and play an
important role in matrix remodeling. The largest sub-family
of the MMPs is membrane-type (MT). MT-MMPs play a dual
role in cell surface proteolysis. They can cleave a variety of
extracellular components, and activate some secreted MMPs.
Evidence has suggested that proteolytic activities at cell surface
could promote cell invasion[50]. MMP-2, a 72-kDa type IV
collagenase, is a cell surface-associated type I collagen-degrading
MMP, which was found to designate gelatinase A[51]. Its
overexpression has been observed in different types of tumors,
and it was believed to be involved in tumor metastasis, primary
tumor growth and angiogenesis[52]. MMP-2 is also regarded as
a type IV collagenase involved in cell invasion across basement
membrane. Thus, serum and tissue MMP profiles have been
used as prognostic factors in certain types of malignant tumors
including gastric and breast cancers[53]. MMP-9, a 97-kDa type
IV collagenase also designating gelatinase B, was found to be
associated with tumor invasion as well, its expression has been
proven to be correlated with the differentiation grade of some
malignancies[54]. In the present study, we did not find any effect
of b-ionone on MMP-9 and MMP-2 activities in SGC-7901
cells. The growth inhibition on SGC-7901 cells appeared to
be independence of the type IV collagenase activity.
     TIMPs (TIMP-1, -2, -3 and -4) have been found to be the
key regulators of MMP activity and ECM degradation[60]. The
MMP inhibitors, TIMP-1 and TIMP-2 have been associated
to several tumorigenic processes including development,
invasion and metastasis of bronchial cancer[55-59]. Recent
transgenic animal studies have demonstrated that alteration of
the MMP/TIMP balance in vivo in favor of TIMP-1 activity
could block neoplastic proliferation in the SV40 T antigen-
induced murine hepatocellular carcinoma[61]. Active MT1-MMP
was found to bind to amino-terminal domain of TIMP-2[62],
whereas an interaction between the carboxyl-terminal domains
of TIMP-2 and pro-MMP-2 was also described[63]. TIMP-2
might prevent SH2-protein-tyrosine phosphatase-1 (SHP-1)
dissociation from immunoprecipitable epidermal growth factor
receptor complex and a selective increase in total SHP-1
activity[64]. Our results showed that b-ionone might increase
the expression of TIMP-1 and TIMP-2 in SGC-7901 cells.
Clearly, further studies are needed to elucidate whether b-
ionone inhibits metastasis of the cancer cells.
     In summary, b-ionone can inhibit SGC-7901 cell growth
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and proliferation and has an effect on upregulating TIMP-1
and TIMP-2 expression in SGC-7901 cells. It seems to be
related to potential tumor metastasis in SGC-7901 cells induced
by b-ionone. However, the mechanism of the inhibitory effect
of b-ionone inhibits cell proliferation remains to be clarified.
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